Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qiagen NV

49.32
-0.0300-0.06%
Post-market: 49.320.00000.00%17:31 EDT
Volume:673.82K
Turnover:33.20M
Market Cap:10.69B
PE:29.13
High:49.53
Open:49.50
Low:49.06
Close:49.35
52wk High:51.88
52wk Low:37.63
Shares:216.83M
Float Shares:214.77M
Volume Ratio:0.90
T/O Rate:0.31%
Dividend:0.25
Dividend Rate:0.51%
EPS(TTM):1.69
EPS(LYR):0.3862
ROE:10.81%
ROA:9.00%
PB:3.05
PE(LYR):127.70

Loading ...

Stock Track | Qiagen Shares Plummet 5.01% Despite Positive Q2 Results, Analysts Maintain Hold Rating

Stock Track
·
Aug 07

Stock Track | Qiagen NV Plummets 5.01% Despite Strong Q2 Results, Analyst Maintains Hold Rating

Stock Track
·
Aug 07

Qiagen NV reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 06

Qiagen Reports Q2 2025 Net Sales $534 Million, Adjusted EPS $0.6

Reuters
·
Aug 06

Qiagen Q2 Adj. EPS $0.60, Inline, Sales $534.000M Beat $523.699M Estimate

Benzinga
·
Aug 06

Qiagen NV expected to post earnings of 60 cents a share - Earnings Preview

Reuters
·
Aug 02

DIARY-Germany corporate earnings week ahead

Reuters
·
Aug 01

Berenberg Lifts Price Target on QIAGEN to EUR50 From EUR48, Keeps Buy Rating

MT Newswires Live
·
Jul 24

QIAGEN NV Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels for Enhanced Genomic Research

Reuters
·
Jul 23

LIVE MARKETS-AI's "low hanging fruit" is in Europe

Reuters
·
Jul 21

Qiagen NV to Release Q2 2025 Financial Results

Reuters
·
Jul 08

Qiagen NV Adjusts Convertible Bond Conversion Price Following Dividend Payment

Reuters
·
Jul 02

Stephen Rusckowski Elected as New Chairman of QIAGEN's Supervisory Board, Succeeding Lawrence Rosen

Reuters
·
Jun 30

QIAGEN N.V. Announces Availability of Managerial Transactions Disclosure

Reuters
·
Jun 28

Qiagen Is Maintained at Buy by B of A Securities

Dow Jones
·
Jun 27

Stephen H. Rusckowski Appointed as Chairman of QIAGEN Supervisory Board; First-Ever Annual Cash Dividend Approved by Shareholders

Reuters
·
Jun 27

Axenio AG Appoints Dr. Helmut Uhl to Executive Board to Drive Strategic Development

Reuters
·
Jun 24

Qiagen Initiated at Overweight by Barclays

Dow Jones
·
Jun 24

QIAGEN Partners with GENCURIX to Develop Multiplex Oncology Assays for QIAcuityDx Platform

Reuters
·
Jun 19

Sector Update: Health Care Stocks Flat to Higher Premarket Monday

MT Newswires Live
·
Jun 16